Re: you won’t see anyone buying this

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: you won’t see anyone buying this

in response to

Re: you won’t see anyone buying this

KOO-KOO2

posted on Dec 06, 2023 11:56AM

Thanks KK2. 36% dilution over the last 2 years alone. That means every royalty distribution will be more than 1/3 less forever. That's assuming we have salable drugs that hit the market.